HITADO GmbH HITADO BTAstat Test Rapid Test
SKU: SKU:
PZN: PZN:
Packaging unit: VE:
in stock: Delivered in 1-3 working days
Verpackungseinheit :
Couldn't load pickup availability
The HITADO BTAstat test is an immunochromatographic in vitro rapid test for the qualitative detection of the bladder tumor antigen hCFHrp (human complement factor H-related protein) in urine. The test is designed for professional use and enables a rapid, preliminary assessment directly at the point of care.
Application areas
– Supportive diagnostics for urological issues
– Use in the context of monitoring progress in cases of known findings, according to professional assessment
– Application in doctors' offices, clinics and urological facilities
– Point-of-care testing with random urine samples
– Use as a supplement to other diagnostic procedures
Advantages at a glance
– Qualitative detection of the bladder tumor antigen hCFHrp
– Easy application with spontaneous urine
– Small sample size required (3 drops)
– Test result within approximately 5 minutes
– Immunochromatographic test principle using monoclonal antibodies
– FDA approved
– Intended for professional in-vitro diagnostic use
Further information
The HITADO BTAstat test provides an indicative test result and does not replace a medical diagnosis or further diagnostic measures. Results should always be evaluated in the context of the overall clinical picture and any additional examinations. The compact test procedure supports rapid decision-making in everyday clinical practice.
– Application: In-vitro diagnostic drug
– Target group: professional use
Manufacturer:
HITADO GmbH
Dreihausen 2
59519 Möhnesee
Deutschland
Tel: +49 (0) 2924 97 05 - 0
Email: info@hitado.de
VAT ID number:
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Delivery information:
WEEE number:
Assistive device number: